The University of Chicago Header Logo

Connection

Emily Rogalski to Longitudinal Studies

Back to Details
This is a "connection" page, showing publications Emily Rogalski has written about Longitudinal Studies.
Emily Rogalski
Connection Strength
1.076
Longitudinal Studies
  1. Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia. Neurology. 2021 02 09; 96(6):e916-e925.
    View in: PubMed
    Score: 0.144
  2. Clinical and cortical decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2019 04; 15(4):543-552.
    View in: PubMed
    Score: 0.126
  3. Word comprehension in temporal cortex and Wernicke area: A PPA perspective. Neurology. 2019 01 15; 92(3):e224-e233.
    View in: PubMed
    Score: 0.125
  4. Rates of Cortical Atrophy in Adults 80 Years and Older With Superior vs Average Episodic Memory. JAMA. 2017 04 04; 317(13):1373-1375.
    View in: PubMed
    Score: 0.111
  5. Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology. 2016 Sep 27; 87(13):1337-43.
    View in: PubMed
    Score: 0.106
  6. A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce. JAMA Netw Open. 2024 Aug 01; 7(8):e2427073.
    View in: PubMed
    Score: 0.046
  7. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S64-S73.
    View in: PubMed
    Score: 0.043
  8. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S29-S41.
    View in: PubMed
    Score: 0.043
  9. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimers Dement. 2023 11; 19 Suppl 9:S115-S125.
    View in: PubMed
    Score: 0.043
  10. Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S42-S48.
    View in: PubMed
    Score: 0.042
  11. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement. 2023 11; 19 Suppl 9:S8-S18.
    View in: PubMed
    Score: 0.042
  12. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods. Alzheimers Dement. 2022 08; 18(8):1449-1460.
    View in: PubMed
    Score: 0.038
  13. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 12; 17(12):2043-2055.
    View in: PubMed
    Score: 0.037
  14. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):49-59.
    View in: PubMed
    Score: 0.034
  15. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21.
    View in: PubMed
    Score: 0.033
  16. Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia. JAMA Neurol. 2016 07 01; 73(7):846-52.
    View in: PubMed
    Score: 0.026
  17. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain. 2012 May; 135(Pt 5):1537-53.
    View in: PubMed
    Score: 0.020
  18. Quantitative template for subtyping primary progressive aphasia. Arch Neurol. 2009 Dec; 66(12):1545-51.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.